NASDAQ:CNC 6 February 2026

July 10, 2026, 7:05 AM EDT. Mergers and acquisitions (M&A) in global healthcare are picking up pace, with pharma firms trying to make up for revenue lost to expiring patents. That has ASX healthcare names in focus as possible buyout or partnership targets. Analysts say Big Pharma wants new treatments and fuller pipelines, which could bring more deals. ASX-listed healthcare stocks stand out for growth and innovation, making them attractive. Investors are watching for moves that could shift values and shake up the sector.